You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries
|
---|---|
Published in |
PharmacoEconomics, October 2015
|
DOI | 10.1007/s40273-015-0328-1 |
Pubmed ID | |
Authors |
EUnetHTA Joint Action 2, Work Package 7, Subgroup 3, Emelie Heintz, Andreas Gerber-Grote, Salah Ghabri, Francoise F. Hamers, Valentina Prevolnik Rupel, Renata Slabe-Erker, Thomas Davidson |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Australia | 2 | 25% |
Sweden | 2 | 25% |
Canada | 1 | 13% |
New Zealand | 1 | 13% |
Spain | 1 | 13% |
Unknown | 1 | 13% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 63% |
Science communicators (journalists, bloggers, editors) | 2 | 25% |
Scientists | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 77 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 14 | 18% |
Researcher | 11 | 14% |
Other | 9 | 12% |
Student > Ph. D. Student | 9 | 12% |
Student > Bachelor | 5 | 6% |
Other | 7 | 9% |
Unknown | 22 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 16 | 21% |
Pharmacology, Toxicology and Pharmaceutical Science | 12 | 16% |
Economics, Econometrics and Finance | 9 | 12% |
Psychology | 4 | 5% |
Social Sciences | 2 | 3% |
Other | 9 | 12% |
Unknown | 25 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2016.
All research outputs
#6,981,937
of 26,017,215 outputs
Outputs from PharmacoEconomics
#797
of 2,008 outputs
Outputs of similar age
#77,100
of 293,486 outputs
Outputs of similar age from PharmacoEconomics
#9
of 22 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 2,008 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 293,486 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.